# 117-hr-7474: Pharmaceutical Research Transparency Act of 2022

117-hr-7474, Pharmaceutical Research Transparency Act of 2022, is a 117th Congress bill sponsored by Rep. Maloney, Carolyn B. [D-NY-12] (D-NY); status Referred to the Subcommittee on Health. (as of 2025-11-18).

- Canonical: https://policyrisk.com/legislation/117-hr-7474
- As of: 2025-11-18
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 117-hr-7474
- Congress: 117
- Title: Pharmaceutical Research Transparency Act of 2022
- Status: Referred to the Subcommittee on Health.
- Introduced: 2022-04-07
- Sponsor: Rep. Maloney, Carolyn B. [D-NY-12] (D-NY)
- Cosponsors: 15
- Policy area: Health
- Touches household money: no
- Last recorded action: 2025-11-18

## Summary

Pharmaceutical Research Transparency Act of 2022 This bill requires the disclosure of costs associated with clinical trials and pharmaceutical research and development. Specifically, the National Institutes of Health must create a publicly available repository of cost data from certain clinical trials that test the efficacy of drugs, biological products, and devices in human subjects. For each applicable trial, the registry must, among other information, include the total and per patient cost of the trial, as well as costs for personnel, health care services, and other categories of expenditures. Information must be added to the registry within one year of the trial's completion. The bill also requires drug manufacturers to include their research and development expenditures for drugs and biological products in annual disclosures made to the Securities and Exchange Commission.

## Cosponsors (15)

- Rep. Schakowsky, Janice D. [D-IL-9] (D-IL), 2022-04-07T00:00:00.000Z
- Sen. Welch, Peter [D-VT] (D-VT), 2022-04-07T00:00:00.000Z
- Rep. Porter, Katie [D-CA-47] (D-CA), 2022-04-07T00:00:00.000Z
- Rep. DeSaulnier, Mark [D-CA-10] (D-CA), 2022-04-07T00:00:00.000Z
- Rep. Raskin, Jamie [D-MD-8] (D-MD), 2022-04-07T00:00:00.000Z
- Rep. Kuster, Ann M. [D-NH-2] (D-NH), 2022-09-13T00:00:00.000Z
- Del. Norton, Eleanor Holmes [D-DC-At Large] (D-DC), 2022-09-13T00:00:00.000Z
- Rep. Grijalva, Raúl M. [D-AZ-7] (D-AZ), 2022-09-13T00:00:00.000Z
- Rep. Scanlon, Mary Gay [D-PA-5] (D-PA), 2022-09-28T00:00:00.000Z
- Rep. Takano, Mark [D-CA-39] (D-CA), 2022-09-28T00:00:00.000Z
- Rep. DeFazio, Peter A. [D-OR-4] (D-OR), 2022-09-28T00:00:00.000Z
- Rep. Chu, Judy [D-CA-28] (D-CA), 2022-11-14T00:00:00.000Z
- Rep. Barragán, Nanette Diaz [D-CA-44] (D-CA), 2022-11-14T00:00:00.000Z
- Rep. Pocan, Mark [D-WI-2] (D-WI), 2022-11-14T00:00:00.000Z
- Rep. Jayapal, Pramila [D-WA-7] (D-WA), 2022-11-29T00:00:00.000Z

## Related bills

- 117-hr-8404: Respect for Marriage Act
- 117-hr-8297: Ensuring Women’s Right to Reproductive Freedom Act
- 117-hjres-87: Directing the removal of United States Armed Forces from hostilities in the Republic of Yemen that have not been authorized by Congress.
- 117-hr-6860: Latonya Reeves Freedom Act of 2022
- 117-hr-6117: PrEP Access and Coverage Act
- 117-hr-6015: Benjamin Berell Ferencz Congressional Gold Medal Act

## Sources
- [117-hr-7474 on Congress.gov](https://www.congress.gov/bill/117th-congress/house-bill/7474)

## Related
- [117-hr-8404: Respect for Marriage Act](https://policyrisk.com/legislation/117-hr-8404)
- [117-hr-8297: Ensuring Women’s Right to Reproductive Freedom Act](https://policyrisk.com/legislation/117-hr-8297)
- [117-hjres-87: Directing the removal of United States Armed Forces from hostilities in the Rep…](https://policyrisk.com/legislation/117-hjres-87)
- [117-hr-6860: Latonya Reeves Freedom Act of 2022](https://policyrisk.com/legislation/117-hr-6860)
- [117-hr-6117: PrEP Access and Coverage Act](https://policyrisk.com/legislation/117-hr-6117)
- [117-hr-6015: Benjamin Berell Ferencz Congressional Gold Medal Act](https://policyrisk.com/legislation/117-hr-6015)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/117-hr-7474 (as of 2025-11-18).